AKT1 and breast cancer: The forced expression of PIK3R1 possesses the ability to significantly enhance paclitaxel resistance in BC cells and xenograft tumors and enhanced PIK3R1 expression also leads to activated phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) (16).